Table 1.

Patients demographics

		N (%)
Total patients		104(100)
Menopause status	Pre	43
	Peri	11
	Post	50
Family risk profile	Positive	11
	Negative	93
BRCA-1	Positive	1
	Negative	27
	Unknown	76
BRCA-2	Positive	2
	Negative	26
	Unknown	76
Ki 67	Positive (> 14%)	88
	Negative (< 14%)	16
PR status	Positive	74
	Negative	30
ER status	Positive	77
	Negative	27
HER2-neu expression	0	42
	1+	33
	2+	11
	3+	18
Subtype	Luminal a	12
	Luminal b	74
	HER2-enriched	2
	Basal-like	16
Tumor Grade	G1	2
	G2	60
	G3	42
Histology	Ductal invasive/NST	97
	Lobular invasive	5
	Mucinous invasive	1
	Mixed type	1